Key recent advances in TB vaccine development and understanding of protective immune responses against mycobacterium tuberculosis
Tuberculosis is the leading infectious disease killer globally due to a single pathogen. Despite wide deployment of standard drug regimens, modern diagnostics and a vaccine (bacille Calmette Guerin, BCG), the global tuberculosis epidemic is inadequately controlled. Novel, effective vaccine(s) are a...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/16421
- Acceso en línea:
- https://doi.org/10.1016/j.smim.2020.101431
http://hdl.handle.net/20.500.12010/16421
- Palabra clave:
- Tuberculosis (TB)
Vaccine(s)
Adaptive immunity
Innate training
Correlates of protection
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)